{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:55:51Z","timestamp":1787313351661,"version":"build-2736575974"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Large-scale disease overarching longitudinal data are rare in the field of neuroimmunology. However, such data could aid early disease stratification, understanding disease etiology and ultimately improve treatment decisions. The Berlin Registry of Neuroimmunological Entities (BERLimmun) is a longitudinal prospective observational study, which aims to identify diagnostic, disease activity and prognostic markers and to elucidate the underlying pathobiology of neuroimmunological diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>BERLimmun is a single-center prospective observational study of planned 650 patients with neuroimmunological disease entity (e.g. but not confined to: multiple sclerosis, isolated syndromes, neuromyelitis optica spectrum disorders) and 85 healthy participants with 15 years of follow-up. The protocol comprises annual in-person visits with multimodal standardized assessments of medical history, rater-based disability staging, patient-report of lifestyle, diet, general health and disease specific symptoms, tests of motor, cognitive and visual functions, structural imaging of the neuroaxis and retina and extensive sampling of biological specimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The BERLimmun database allows to investigate multiple key aspects of neuroimmunological diseases, such as immunological differences between diagnoses or compared to healthy participants, interrelations between findings of functional impairment and structural change, trajectories of change for different biomarkers over time and, importantly, to study determinants of the long-term disease course. BERLimmun opens an opportunity to a better understanding and distinction of neuroimmunological diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-022-02986-7","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T03:03:09Z","timestamp":1670986989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Berlin Registry of Neuroimmunological entities (BERLimmun): protocol of a prospective observational study"],"prefix":"10.1186","volume":"22","author":[{"given":"Pia S.","family":"Sperber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander U.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna G.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina S.","family":"Bahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Rekers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"M\u00e4hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chotima","family":"B\u00f6ttcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Asseyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankelien Solveig","family":"Duchow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Bellmann-Strobl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Ruprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Schmitz-H\u00fcbsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"key":"2986_CR1","doi-asserted-by":"publisher","unstructured":"Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B. Neuromyelitis Optica. Vol.\u00a06: Springer US; 2020. doi:https:\/\/doi.org\/10.1038\/s41572-020-0214-9.","DOI":"10.1038\/s41572-020-0214-9"},{"issue":"September","key":"2986_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1474-4422(21)00218-0","volume":"20","author":"R Marignier","year":"2021","unstructured":"Marignier R, Hacohen Y, Cobo-calvo A, et al. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021;20(September):1. https:\/\/doi.org\/10.1016\/S1474-4422(21)00218-0.","journal-title":"Lancet Neurol."},{"key":"2986_CR3","doi-asserted-by":"crossref","unstructured":"Abbatemarco JR, Rodenbeck SJ, Day GS, Titulaer MJ, Yeshokumar AK, Clardy SL. Autoimmune neurology: the need for Comprehensive Care. Neurol Neuroimmunol Neuroinflamm. 2021;8(5).","DOI":"10.1212\/NXI.0000000000001033"},{"key":"2986_CR4","doi-asserted-by":"publisher","unstructured":"Makary MA, Daniel M. Medical error \u2014 the third leading cause of death in the. BMJ. 2016;2139(May):1\u20135. https:\/\/doi.org\/10.1136\/bmj.i2139.","DOI":"10.1136\/bmj.i2139"},{"issue":"9","key":"2986_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nrneurol.2017.106","volume":"13","author":"AJ Solomon","year":"2017","unstructured":"Solomon AJ, Corboy JR. The tension between early diagnosis and misdiagnosis of multiple sclerosis. Nat Rev Neurol. 2017;13(9):567\u201372. doi:https:\/\/doi.org\/10.1038\/nrneurol.2017.106.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"2986_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1759-1961.2012.00030.x","volume":"3","author":"K Fujihara","year":"2012","unstructured":"Fujihara K, Misu T, Nakashima I, et al. Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease. Clin Exp Neuroimmunol. 2012;3(2):58\u201373. doi:https:\/\/doi.org\/10.1111\/j.1759-1961.2012.00030.x.","journal-title":"Clin Exp Neuroimmunol"},{"issue":"1","key":"2986_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Ruprecht K, Wildemann B, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation. 2012;9(1):14. doi:https:\/\/doi.org\/10.1186\/1742-2094-9-14.","journal-title":"J Neuroinflammation"},{"issue":"21","key":"2986_CR8","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1212\/WNL.0000000000005619","volume":"90","author":"Y Hacohen","year":"2018","unstructured":"Hacohen Y, Palace J. Time to separate MOG-Ab-associated disease from AQP4-Ab-positive neuromyelitis optica spectrum disorder. Neurology. 2018;90(21):947\u20138. doi:https:\/\/doi.org\/10.1212\/WNL.0000000000005619.","journal-title":"Neurology"},{"issue":"5","key":"2986_CR9","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/S0140-6736(01)35140-1","volume":"25","author":"BJL Bennett","year":"2019","unstructured":"Bennett BJL. Optic Neuritis. Lancet. 2019;25(5):1236\u201364. doi:https:\/\/doi.org\/10.1016\/S0140-6736(01)35140-1.","journal-title":"Lancet"},{"issue":"5","key":"2986_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/NXI.0000000000000270","volume":"3","author":"DP Kidd","year":"2016","unstructured":"Kidd DP, Burton BJ, Graham EM, Plant GT. Optic neuropathy associated with systemic sarcoidosis. Neurol Neuroimmunol NeuroInflammation. 2016;3(5):1\u20137. doi:https:\/\/doi.org\/10.1212\/NXI.0000000000000270.","journal-title":"Neurol Neuroimmunol NeuroInflammation"},{"key":"2986_CR11","doi-asserted-by":"crossref","unstructured":"Graves JS, Oertel FC, Van der Walt A, et al. Leveraging Visual Outcome Measures to Advance Therapy Development in Neuroimmunologic Disorders. Neurol Neuroimmunol neuroinflammation. 2022;9(2).","DOI":"10.1212\/NXI.0000000000001126"},{"issue":"6","key":"2986_CR12","doi-asserted-by":"publisher","first-page":"e1068","DOI":"10.1212\/nxi.0000000000001068","volume":"8","author":"FC Oertel","year":"2021","unstructured":"Oertel FC, Specovius S, Zimmermann HG, et al. Retinal optical coherence tomography in Neuromyelitis Optica. Neurol - Neuroimmunol Neuroinflammation. 2021;8(6):e1068. doi:https:\/\/doi.org\/10.1212\/nxi.0000000000001068.","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"issue":"8","key":"2986_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrneurol.2014.108","volume":"10","author":"A Petzold","year":"2014","unstructured":"Petzold A, Wattjes MP, Costello F, et al. The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol. 2014;10(8):447\u201358. doi:https:\/\/doi.org\/10.1038\/nrneurol.2014.108.","journal-title":"Nat Rev Neurol"},{"key":"2986_CR14","doi-asserted-by":"crossref","unstructured":"Avasarala J, Pettigrew C, Sutton P, et al. Can a diagnosis of multiple sclerosis be made without ruling out neuromyelitis optica spectrum disorder\u202f? Mult Scler Relat Disord. 2020;40.","DOI":"10.1016\/j.msard.2020.101949"},{"issue":"4","key":"2986_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrneurol.2018.14","volume":"14","author":"R Geraldes","year":"2018","unstructured":"Geraldes R, Ciccarelli O, Barkhof F, et al. The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nat Rev Neurol. 2018;14(4):199\u2013213. doi:https:\/\/doi.org\/10.1038\/nrneurol.2018.14.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"2986_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1352458517751049","volume":"24","author":"X Montalban","year":"2018","unstructured":"Montalban X, Gold R, Thompson AJ, et al. ECTRIMS\/EAN Guideline on the pharmacological treatment of people with multiple sclerosis. Mult Scler. 2018;24(2):96\u2013120. doi:https:\/\/doi.org\/10.1177\/1352458517751049.","journal-title":"Mult Scler"},{"issue":"1","key":"2986_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","volume":"261","author":"C Trebst","year":"2014","unstructured":"Trebst C, Jarius S, Berthele A, et al. Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol. 2014;261(1):1\u201316. doi:https:\/\/doi.org\/10.1007\/s00415-013-7169-7.","journal-title":"J Neurol"},{"issue":"7","key":"2986_CR18","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3174\/ajnr.A5665","volume":"39","author":"C Chien","year":"2018","unstructured":"Chien C, Brandt AU, Schmidt F, et al. MRI-based methods for spinal cord atrophy evaluation: a comparison of cervical cord cross-sectional area, cervical cord volume, and full spinal cord volume in patients with aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders. Am J Neuroradiol. 2018;39(7):1362\u20138. doi:https:\/\/doi.org\/10.3174\/ajnr.A5665.","journal-title":"Am J Neuroradiol"},{"issue":"00","key":"2986_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08820538.2020.1866027","volume":"00","author":"A Winter","year":"2021","unstructured":"Winter A, Chwalisz B. MRI characteristics of NMO, MOG and MS related Optic Neuritis. Semin Ophthalmol. 2021;00(00):1\u201310. doi:https:\/\/doi.org\/10.1080\/08820538.2020.1866027.","journal-title":"Semin Ophthalmol"},{"issue":"6","key":"2986_CR20","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/1352458514567216","volume":"21","author":"JL Bennett","year":"2015","unstructured":"Bennett JL, de Seze J, Lana-Peixoto M, et al. Neuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomography. Mult Scler J. 2015;21(6):678\u201388. doi:https:\/\/doi.org\/10.1177\/1352458514567216.","journal-title":"Mult Scler J"},{"issue":"9","key":"2986_CR21","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1001\/jamaneurol.2018.1011","volume":"75","author":"HG Zimmermann","year":"2018","unstructured":"Zimmermann HG, Knier B, Oberwahrenbrock T, et al. Association of retinal ganglion cell layer thickness with future disease activity in patients with clinically isolated syndrome. JAMA Neurol. 2018;75(9):1071\u20139. doi:https:\/\/doi.org\/10.1001\/jamaneurol.2018.1011.","journal-title":"JAMA Neurol"},{"issue":"15","key":"2986_CR22","doi-asserted-by":"publisher","first-page":"e1439","DOI":"10.1212\/WNL.0000000000008237","volume":"93","author":"C Pfuhl","year":"2019","unstructured":"Pfuhl C, Grittner U, Gie\u00df RM, et al. Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis. Neurology. 2019;93(15):e1439\u201351. doi:https:\/\/doi.org\/10.1212\/WNL.0000000000008237.","journal-title":"Neurology"},{"issue":"March","key":"2986_CR23","doi-asserted-by":"publisher","first-page":"102608","DOI":"10.1016\/j.nicl.2021.102608","volume":"30","author":"A Papadopoulou","year":"2021","unstructured":"Papadopoulou A, Oertel FC, Chien C, et al. Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: a longitudinal study. NeuroImage Clin. 2021;30(March):102608. doi:https:\/\/doi.org\/10.1016\/j.nicl.2021.102608.","journal-title":"NeuroImage Clin"},{"issue":"2","key":"2986_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162\u201373. doi:https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2.","journal-title":"Lancet Neurol"},{"issue":"5","key":"2986_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1212\/WNL.0000000000002366","volume":"86","author":"DM Wingerchuk","year":"2016","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2016;86(5):491\u20132. doi:https:\/\/doi.org\/10.1212\/WNL.0000000000002366.","journal-title":"Neurology"},{"issue":"11","key":"2986_CR26","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444\u201352.","journal-title":"Neurology"},{"issue":"3","key":"2986_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.msard.2015.04.001","volume":"4","author":"L Kappos","year":"2015","unstructured":"Kappos L, D\u2019Souza M, Lechner-Scott J, Lienert C. On the origin of Neurostatus. Mult Scler Relat Disord. 2015;4(3):182\u20135. doi:https:\/\/doi.org\/10.1016\/j.msard.2015.04.001.","journal-title":"Mult Scler Relat Disord"},{"key":"2986_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/B978-0-12-374105-9.00534-7","volume":"1","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch T. Scale for the Assessment and Rating of Ataxia (SARA). Neurology. 2006;1:95\u20139. https:\/\/doi.org\/10.1016\/B978-0-12-374105-9.00534-7.","journal-title":"Neurology."},{"issue":"2","key":"2986_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.apmr.2016.07.023","volume":"98","author":"S Winser","year":"2017","unstructured":"Winser S, Smith CM, Hale LA, et al. Psychometric Properties of a Core Set of Measures of Balance for people with cerebellar Ataxia secondary to multiple sclerosis. Arch Phys Med Rehabil. 2017;98(2):270\u20136. doi:https:\/\/doi.org\/10.1016\/j.apmr.2016.07.023.","journal-title":"Arch Phys Med Rehabil"},{"issue":"1\u20132","key":"2986_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","volume":"291","author":"S Jarius","year":"2010","unstructured":"Jarius S, Probst C, Borowski K, et al. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci. 2010;291(1\u20132):52\u20136. doi:https:\/\/doi.org\/10.1016\/j.jns.2010.01.002.","journal-title":"J Neurol Sci"},{"issue":"2","key":"2986_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/NXI.0000000000000674","volume":"7","author":"M Reindl","year":"2020","unstructured":"Reindl M, Schanda K, Woodhall M, et al. International multicenter examination of MOG antibody assays. Neurol Neuroimmunol neuroinflammation. 2020;7(2):1\u201312. doi:https:\/\/doi.org\/10.1212\/NXI.0000000000000674.","journal-title":"Neurol Neuroimmunol neuroinflammation"},{"issue":"9","key":"2986_CR32","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1136\/jnnp-2015-312601","volume":"87","author":"P Waters","year":"2016","unstructured":"Waters P, Reindl M, Saiz A, et al. Multicentre comparison of a diagnostic assay: Aquaporin-4 antibodies in neuromyelitis optica. J Neurol Neurosurg Psychiatry. 2016;87(9):1005\u201315. doi:https:\/\/doi.org\/10.1136\/jnnp-2015-312601.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"2986_CR33","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1007\/s00415-020-10024-0","volume":"267","author":"M Gastaldi","year":"2020","unstructured":"Gastaldi M, Scaranzin S, Jarius S, et al. Cell-based assays for the detection of MOG antibodies: a comparative study. J Neurol. 2020;267(12):3555\u201364. doi:https:\/\/doi.org\/10.1007\/s00415-020-10024-0.","journal-title":"J Neurol"},{"key":"2986_CR34","doi-asserted-by":"publisher","first-page":"103307","DOI":"10.1016\/j.msard.2021.103307","volume":"56","author":"S Simpson-Yap","year":"2021","unstructured":"Simpson-Yap S, Nag N, Jakaria M, Jelinek GA, Neate S. Sociodemographic and clinical characteristics of diet adherence and relationship with diet quality in an international cohort of people with multiple sclerosis. Mult Scler Relat Disord. 2021;56:103307. doi:https:\/\/doi.org\/10.1016\/j.msard.2021.103307.","journal-title":"Mult Scler Relat Disord"},{"issue":"SUPPL. 1","key":"2986_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/ije\/26.suppl_1.S71","volume":"26","author":"S Bohlscheid-Thomas","year":"1997","unstructured":"Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J. Reproducibility and relative validity of energy and macronutrient intake of a food frequency questionnaire developed for the german part of the EPIC project. Int J Epidemiol. 1997;26(SUPPL. 1):71\u201381. doi:https:\/\/doi.org\/10.1093\/ije\/26.suppl_1.S71.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2986_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12010160","volume":"12","author":"SAJ Koch","year":"2020","unstructured":"Koch SAJ, Conrad J, Hierath L, et al. Adaptation and evaluation of myfood24-germany: a web-based self-administered 24-h dietary recall for the german adult population. Nutrients. 2020;12(1):1\u201315. doi:https:\/\/doi.org\/10.3390\/nu12010160.","journal-title":"Nutrients"},{"issue":"1","key":"2986_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-018-1113-8","volume":"16","author":"PA Wark","year":"2018","unstructured":"Wark PA, Hardie LJ, Frost GS, et al. Validity of an online 24-h recall tool (myfood24) for dietary assessment in population studies: comparison with biomarkers and standard interviews. BMC Med. 2018;16(1):1\u201314. doi:https:\/\/doi.org\/10.1186\/s12916-018-1113-8.","journal-title":"BMC Med"},{"key":"2986_CR38","unstructured":"Palylyk-Colwell E, Ford C. Flash glucose monitoring system for diabetes. In: Ottawa (ON); 2016:1\u201313."},{"issue":"3","key":"2986_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12030744","volume":"12","author":"E Drehmer","year":"2020","unstructured":"Drehmer E, Platero JL, Carrera-Juli\u00e1 S, et al. The relation between eating habits and abdominal fat, anthropometry, PON1 and IL-6 levels in patients with multiple sclerosis. Nutrients. 2020;12(3):1\u201310. doi:https:\/\/doi.org\/10.3390\/nu12030744.","journal-title":"Nutrients"},{"issue":"9","key":"2986_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/brb3.1350","volume":"9","author":"X Chen","year":"2019","unstructured":"Chen X, Fan R, Peng F, et al. Blood pressure and body fat percent in women with NMOSD. Brain Behav. 2019;9(9):1\u20139. doi:https:\/\/doi.org\/10.1002\/brb3.1350.","journal-title":"Brain Behav"},{"issue":"5","key":"2986_CR41","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.clinthera.2008.05.011","volume":"30","author":"JT Farrar","year":"2008","unstructured":"Farrar JT, Troxel AB, Stott C, Duncombe P, Jensen MP. Validity, reliability, and clinical importance of change in a 0\u201310 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. Clin Ther. 2008;30(5):974\u201385. doi:https:\/\/doi.org\/10.1016\/j.clinthera.2008.05.011.","journal-title":"Clin Ther"},{"issue":"2","key":"2986_CR42","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2466\/03.27.PMS.120v19x7","volume":"120","author":"S Amireault","year":"2015","unstructured":"Amireault S, Godin G. The godin-shephard leisure-time physical activity questionnaire: Validity evidence supporting its use for classifying healthy adults into active and insufficiently active categories. Percept Mot Skills. 2015;120(2):604\u201322. doi:https:\/\/doi.org\/10.2466\/03.27.PMS.120v19x7.","journal-title":"Percept Mot Skills"},{"issue":"April 1993","key":"2986_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1212\/WNL.45.2.251","volume":"45","author":"MJ Hohol","year":"1995","unstructured":"Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis. Neurology. 1995;45(April 1993):251\u20135.","journal-title":"Neurology"},{"issue":"1","key":"2986_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1212\/WNL.60.1.31","volume":"60","author":"JC Hobart","year":"2003","unstructured":"Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability: the 12-item MS walking scale (MSWS-12). Neurology. 2003;60(1):31\u20136. doi:https:\/\/doi.org\/10.1212\/WNL.60.1.31.","journal-title":"Neurology"},{"issue":"6","key":"2986_CR45","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00391-007-0504-9","volume":"41","author":"N Schott","year":"2008","unstructured":"Schott N. Deutsche Adaptation der \u201cActivities-Specific balance confidence (ABC) Scale\u201d zur Erfassung der Sturzassoziierten Selbstwirksamkeit. Z Gerontol Geriatr. 2008;41(6):475\u201385. doi:https:\/\/doi.org\/10.1007\/s00391-007-0504-9.","journal-title":"Z Gerontol Geriatr"},{"issue":"10","key":"2986_CR46","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121\u20133.","journal-title":"Arch Neurol"},{"issue":"12","key":"2986_CR47","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1177\/1352458509348519","volume":"15","author":"IK Penner","year":"2009","unstructured":"Penner IK, Raselli C, St\u00f6cklin M, Opwis K, Kappos L, Calabrese P. The fatigue scale for motor and cognitive functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler. 2009;15(12):1509\u201317. doi:https:\/\/doi.org\/10.1177\/1352458509348519.","journal-title":"Mult Scler"},{"issue":"1","key":"2986_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7224\/1537-2073.2012-047","volume":"16","author":"H Becker","year":"2014","unstructured":"Becker H, Stuifbergen A, Lee HY, Kullberg V. Reliability and validity of PROMIS cognitive abilities and cognitive concerns scales among people with multiple sclerosis. Int J MS Care. 2014;16(1):1\u20139. doi:https:\/\/doi.org\/10.7224\/1537-2073.2012-047.","journal-title":"Int J MS Care"},{"key":"2986_CR49","doi-asserted-by":"crossref","unstructured":"Radbruch L, Loick G, Kiencke P, et al. Validation of the german version of the brief Pain Inventory. J Pain Symptom Manage. 1999;18(3):180\u20137.\u00a0https:\/\/doi.org\/10.1016\/j.beth.2017.10.003%0Ahttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8826494%0Ahttp:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2237-60892013000300007&lng=en&tlng=en%0Ahttps:\/\/www5.bahiana.edu.br\/index.php\/fisioterapia\/article\/view\/1080","DOI":"10.1016\/S0885-3924(99)00064-0"},{"issue":"10","key":"2986_CR50","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1185\/030079906X132488","volume":"22","author":"R Freynhagen","year":"2006","unstructured":"Freynhagen R, Baron R, Gockel U, T\u00f6lle TR. painDETECT. A new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22(10):1911\u201320. doi:https:\/\/doi.org\/10.1185\/030079906X132488.","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"2986_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/brb3.365","volume":"5","author":"A Fischer","year":"2015","unstructured":"Fischer A, Fischer M, Nicholls RA, et al. Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires. Brain Behav. 2015;5(9):1. https:\/\/doi.org\/10.1002\/brb3.365.","journal-title":"Brain Behav."},{"issue":"2","key":"2986_CR52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1191\/135245801678227649","volume":"7","author":"SM Gold","year":"2001","unstructured":"Gold SM, Heesen C, Schulz H, et al. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in multiple sclerosis (HAQUAMS). Mult Scler. 2001;7(2):119\u201330. doi:https:\/\/doi.org\/10.1191\/135245801678227649.","journal-title":"Mult Scler"},{"issue":"7","key":"2986_CR53","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","volume":"18","author":"RD Hays","year":"2009","unstructured":"Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009;18(7):873\u201380. doi:https:\/\/doi.org\/10.1007\/s11136-009-9496-9.","journal-title":"Qual Life Res"},{"issue":"2","key":"2986_CR54","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1177\/1352458509354552","volume":"16","author":"AS Drake","year":"2010","unstructured":"Drake AS, Weinstock-Guttman B, Morrow SA, Hojnacki D, Munschauer FE, Benedict RHB. Psychometrics and normative data for the multiple sclerosis functional composite: replacing the PASAT with the symbol digit modalities test. Mult Scler. 2010;16(2):228\u201337. doi:https:\/\/doi.org\/10.1177\/1352458509354552.","journal-title":"Mult Scler"},{"issue":"4","key":"2986_CR55","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/135245859900500409","volume":"5","author":"JS Fischer","year":"1999","unstructured":"Fischer JS, Rudick RA, Cutter GR, Reingold SC. The multiple sclerosis functional composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler J. 1999;5(4):244\u201350. doi:https:\/\/doi.org\/10.1177\/135245859900500409.","journal-title":"Mult Scler J"},{"issue":"4","key":"2986_CR56","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/ageing\/afr051","volume":"40","author":"HC Roberts","year":"2011","unstructured":"Roberts HC, Denison HJ, Martin HJ, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011;40(4):423\u20139. doi:https:\/\/doi.org\/10.1093\/ageing\/afr051.","journal-title":"Age Ageing"},{"key":"2986_CR57","doi-asserted-by":"crossref","unstructured":"Otte K, Kayser B, Mansow-Model S, et al. Accuracy and Reliability of the Kinect Version 2 for Clinical Measurement of Motor Function. Maurits NM, ed. PLoS One. 2016;11(11).","DOI":"10.1371\/journal.pone.0166532"},{"issue":"12","key":"2986_CR58","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1177\/1352458515625807","volume":"22","author":"JR Behrens","year":"2016","unstructured":"Behrens JR, Mertens S, Kr\u00fcger T, et al. Validity of visual perceptive computing for static posturography in patients with multiple sclerosis. Mult Scler J. 2016;22(12):1596\u2013606. doi:https:\/\/doi.org\/10.1177\/1352458515625807.","journal-title":"Mult Scler J"},{"key":"2986_CR59","doi-asserted-by":"crossref","unstructured":"Grobelny A, Behrens JR, Mertens S, et al. Maximum walking speed in multiple sclerosis assessed with visual perceptive computing. Sakakibara M, ed. PLoS One. 2017;12(12).","DOI":"10.1371\/journal.pone.0189281"},{"issue":"6","key":"2986_CR60","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1352458511431076","volume":"18","author":"DW Langdon","year":"2012","unstructured":"Langdon DW, Amato MP, Boringa J, et al. Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler J. 2012;18(6):891\u20138. doi:https:\/\/doi.org\/10.1177\/1352458511431076.","journal-title":"Mult Scler J"},{"issue":"11","key":"2986_CR61","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1007\/s00415-018-9034-1","volume":"265","author":"M Filser","year":"2018","unstructured":"Filser M, Schreiber H, P\u00f6ttgen J, Ullrich S, Lang M, Penner IK. The brief International Cognitive Assessment in multiple sclerosis (BICAMS): results from the german validation study. J Neurol. 2018;265(11):2587\u201393. doi:https:\/\/doi.org\/10.1007\/s00415-018-9034-1.","journal-title":"J Neurol"},{"key":"2986_CR62","volume-title":"Symbol Digit Modalities Test (revised)","author":"A Smith","year":"1982","unstructured":"Smith A. Symbol Digit Modalities Test (revised). Los Angeles: Western Psychological Services; 1982. 1982:1982."},{"issue":"5","key":"2986_CR63","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.acn.2006.06.002","volume":"21","author":"SP Woods","year":"2006","unstructured":"Woods SP, Delis DC, Scott JC, Kramer JH, Holdnack JA. The California Verbal Learning Test - second edition: test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms. Arch Clin Neuropsychol. 2006;21(5):413\u201320. doi:https:\/\/doi.org\/10.1016\/j.acn.2006.06.002.","journal-title":"Arch Clin Neuropsychol"},{"key":"2986_CR64","first-page":"1996","volume-title":"Rey auditory verbal learning test: A handbook","author":"M Schmidt","year":"1996","unstructured":"Schmidt M. Rey auditory verbal learning test: A handbook. Los Angeles: Western Psychological Services; 1996. p. 1996."},{"key":"2986_CR65","first-page":"2001","volume-title":"Verbaler Lern-und Merkf\u00e4higkeitstest: VLMT: manual","author":"C Helmstaedter","year":"2001","unstructured":"Helmstaedter C, Lendt M, Lux S. Verbaler Lern-und Merkf\u00e4higkeitstest: VLMT: manual. 1st ed. G\u00f6ttingen: Hogrefe Verlag; 2001. p. 2001.","edition":"1"},{"key":"2986_CR66","volume-title":"Brief Visuospatial Memory test \u2013 revised","author":"RHB Benedict","year":"1997","unstructured":"Benedict RHB. Benedict RHB. Brief Visuospatial Memory test \u2013 revised. Odessa: Psychological Assessment Resources, Inc; 1997. 1997:1997."},{"key":"2986_CR67","doi-asserted-by":"publisher","DOI":"10.1101\/2021.11.19.21266592","volume-title":"Deep learning based intraretinal layer segmentation using cascaded compressed\u00a0U-net","author":"SK Yadav","year":"2021","unstructured":"Yadav SK, Kafieh R, Zimmermann HG, et al. Deep learning based intraretinal layer segmentation\nusing cascaded compressed\u00a0U-net. 2021."},{"issue":"10","key":"2986_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1117\/1.jbo.23.10.106004","volume":"23","author":"SK Yadav","year":"2018","unstructured":"Yadav SK, Kadas EM. Optic nerve head three-dimensional shape analysis. J Biomed Opt. 2018;23(10):1. doi:https:\/\/doi.org\/10.1117\/1.jbo.23.10.106004.","journal-title":"J Biomed Opt"},{"issue":"December","key":"2986_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2020.611194","volume":"14","author":"G Cooper","year":"2020","unstructured":"Cooper G, Hirsch S, Scheel M, et al. Quantitative Multi-Parameter Mapping optimized for the clinical routine. Front Neurosci. 2020;14(December):1\u20139. doi:https:\/\/doi.org\/10.3389\/fnins.2020.611194.","journal-title":"Front Neurosci"},{"issue":"2","key":"2986_CR70","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3174\/ajnr.a6394","volume":"41","author":"C Chien","year":"2020","unstructured":"Chien C, Juenger V, Scheel M, Brandt AU, Paul F. Considerations for mean upper cervical cord area implementation in a longitudinal MRI setting: methods, interrater reliability, and MRI quality control. Am J Neuroradiol. 2020;41(2):343\u201350. doi:https:\/\/doi.org\/10.3174\/ajnr.a6394.","journal-title":"Am J Neuroradiol"},{"issue":"2","key":"2986_CR71","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. doi:https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"2986_CR72","unstructured":"https:\/\/www.who.int\/standards\/classifications International Statistical Classification of Diseases and Related Health Problems (ICD)."},{"key":"2986_CR73","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Oslo N. https:\/\/www.whocc.no\/."},{"issue":"5","key":"2986_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/NXI.0000000000000805","volume":"7","author":"S Motamedi","year":"2020","unstructured":"Motamedi S, Oertel FC, Yadav SK, et al. Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders. Neurol Neuroimmunol neuroinflammation. 2020;7(5):1\u201311. doi:https:\/\/doi.org\/10.1212\/NXI.0000000000000805.","journal-title":"Neurol Neuroimmunol neuroinflammation"},{"issue":"14","key":"2986_CR75","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1177\/1352458518815596","volume":"25","author":"C Chien","year":"2019","unstructured":"Chien C, Scheel M, Schmitz-H\u00fcbsch T, et al. Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity. Mult Scler J. 2019;25(14):1926\u201336. doi:https:\/\/doi.org\/10.1177\/1352458518815596.","journal-title":"Mult Scler J"},{"key":"2986_CR76","doi-asserted-by":"crossref","unstructured":"Concato J, Shah N, Horwitz RI. Randomized controlled trials, observational studies and the hierachy of research designs. N Engl J Med. 2000:1887\u20131892.","DOI":"10.1056\/NEJM200006223422507"},{"key":"2986_CR77","unstructured":"WHO Trial Registration Data Set. (Version 1.3.1). https:\/\/www.who.int\/ictrp\/network\/trds\/en\/."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02986-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02986-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02986-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T03:05:54Z","timestamp":1670987154000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02986-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2986"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02986-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]},"assertion":[{"value":"2 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional ethics committee of Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin (EA1\/362\/20) and we follow guidelines framed by the Declaration of Helsinki for the conduction of the study. Before study entry, each participant gives written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of results will be obtained from all study participants by the study physician.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PSS, AUB, LSB, SR, AM, CB, ASD, FP have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"JBS has received speaking honoraria and travel grants from Bayer Healthcare, sanofi-aventis\/Genzyme, and Biogen, in addition received compensation for serving on a Scientific Advisory board of Roche, not related to the presented work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"HGZ received research grants from Novartis and speaking honoraria from Bayer.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"KR received research support from Novartis Pharma, Merck Serono, German Ministry of Education and Research, European Union (821283-2), Stiftung Charit\u00e9 and Arthur Arnstein Foundation, and travel grants from Guthy Jackson Charitable Foundation.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"TSH received speaker\u2019s honoraria from Bayer and Biogen research funding to institution from Roche pharma and Celgene\/bms.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"SA received a conference grant from Celgene and honoraria for lecturing from Alexion, Bayer, and Roche.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"CC received honoraria for lecturing from Bayer and research funding from Novartis.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"479"}}